Latham & Watkins partner Brad Faris explains the M&A term poison pill, an action taken by a company to make its equity less attractive to potential acquirers in order to prevent being acquired in a hostile takeover. For additional definitions of the legal and business terms often encountered in the structuring, negotiation and execution of mergers, visit www.lw.com/m-and-a